• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

眼眶放射治疗甲状腺眼病：病例报告及文献综述

Orbital radiotherapy for thyroid eye disease: case report with a review of the literature.

作者信息

Luu Andrew

机构信息

Torbay Hospital, Torbay & South Devon NHS Foundation Trust, Torquay, UK.

出版信息

BJR Case Rep. 2016 May 28;2(2):20150385. doi: 10.1259/bjrcr.20150385. eCollection 2016.

DOI:10.1259/bjrcr.20150385
PMID:30363645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6180866/
Abstract

Thyroid eye disease (TED) is a condition mainly associated with Graves' disease. We report a patient with moderate-tosevere TED who underwent a combination of intravenous and oral steroids and orbital radiotherapy that improved her visual acuity and colour vision drastically, and decreased upper lid oedema. We review the clinical features of this unusual condition, our patient's history and treatment, and the knowledge base from the current literature.

摘要

甲状腺眼病（TED）是一种主要与格雷夫斯病相关的病症。我们报告了一名患有中度至重度甲状腺眼病的患者，该患者接受了静脉注射和口服类固醇以及眼眶放射治疗的联合治疗，这极大地改善了她的视力和色觉，并减轻了上睑水肿。我们回顾了这种罕见病症的临床特征、我们患者的病史及治疗情况，以及当前文献中的知识库。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f01/6180866/0ce69a5c82e5/bjrcr.20150385.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f01/6180866/a17ee69b0aa3/bjrcr.20150385.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f01/6180866/0ce69a5c82e5/bjrcr.20150385.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f01/6180866/a17ee69b0aa3/bjrcr.20150385.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f01/6180866/0ce69a5c82e5/bjrcr.20150385.g002.jpg

相似文献

1
Orbital radiotherapy for thyroid eye disease: case report with a review of the literature.眼眶放射治疗甲状腺眼病：病例报告及文献综述
BJR Case Rep. 2016 May 28;2(2):20150385. doi: 10.1259/bjrcr.20150385. eCollection 2016.
2
Orbital radiotherapy plus three-wall orbital decompression in a patient with rare ocular manifestations of thyroid eye disease: case report.眼眶放射治疗联合三壁眼眶减压术治疗罕见眼部表现的甲状腺眼病患者：病例报告
BMC Endocr Disord. 2018 Feb 6;18(1):7. doi: 10.1186/s12902-018-0235-5.
3
Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.甲状腺眼病在 Graves 病伴和不伴眼眶病患者中的认识。
Thyroid. 2019 Apr;29(4):557-562. doi: 10.1089/thy.2018.0665. Epub 2019 Mar 22.
4
Idiopathic orbital myositis associated with Graves' disease.与格雷夫斯病相关的特发性眼眶肌炎。
Intern Med. 2013;52(7):787-90. doi: 10.2169/internalmedicine.52.9162. Epub 2013 Apr 1.
5
A treatment strategy for Graves' orbitopathy.格雷夫斯眼眶病的治疗策略。
Nat Clin Pract Endocrinol Metab. 2007 May;3(5):430-6. doi: 10.1038/ncpendmet0500.
6
Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?中重度格雷夫斯眼病的皮质类固醇治疗：口服还是静脉治疗？
Int J Environ Res Public Health. 2019 Jan 8;16(1):155. doi: 10.3390/ijerph16010155.
7
Secondary malignancy following radiotherapy for thyroid eye disease.甲状腺眼病放疗后的继发性恶性肿瘤。
Rep Pract Oncol Radiother. 2016 May-Jun;21(3):156-61. doi: 10.1016/j.rpor.2016.01.001. Epub 2016 Feb 8.
8
Thyroid eye disease: therapy in the active phase.甲状腺眼病：活动期的治疗
J Neuroophthalmol. 2014 Jun;34(2):186-97. doi: 10.1097/WNO.0000000000000128.
9
Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?甲状腺眼病的发病机制——抗 TSH 受体自身免疫能否解释所有病例？
Endokrynol Pol. 2010 Mar-Apr;61(2):222-7.
10
[Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].[甲状腺眼病的发病机制——针对促甲状腺激素受体的自身免疫能解释所有病例吗？]
Endokrynol Pol. 2011;62 Suppl 1:1-7.

本文引用的文献

1
Orbital radiation therapy for Graves' ophthalmopathy: measuring clinical efficacy and impact.眼眶放射治疗Graves眼病：评估临床疗效及影响
Pract Radiat Oncol. 2014 Jul-Aug;4(4):233-9. doi: 10.1016/j.prro.2014.02.008. Epub 2014 Apr 3.
2
Comparative analysis of dosimetric parameters of three different radiation techniques for patients with Graves' ophthalmopathy treated with retro-orbital irradiation.三种不同放射技术治疗格雷夫斯眼病患者眶后放射的剂量学参数比较分析。
Radiat Oncol. 2012 Nov 26;7:199. doi: 10.1186/1748-717X-7-199.
3
Feasibility of tomotherapy for Graves' ophthalmopathy: Dosimetry comparison with conventional radiotherapy.
经颅磁刺激治疗 Graves 眼病的可行性：与常规放射治疗的剂量学比较。
Strahlenther Onkol. 2011 Sep;187(9):568-74. doi: 10.1007/s00066-011-2220-z. Epub 2011 Jun 28.
4
Selenium and the course of mild Graves' orbitopathy.硒与轻度格雷夫斯眼病的病程。
N Engl J Med. 2011 May 19;364(20):1920-31. doi: 10.1056/NEJMoa1012985.
5
Protracted hypofractionated radiotherapy for Graves' ophthalmopathy: a pilot study of clinical and radiologic response.Graves 眼病的迁延性低分割放射治疗：临床和影像学反应的初步研究。
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1285-91. doi: 10.1016/j.ijrobp.2010.09.015. Epub 2011 May 6.
6
Graves' ophthalmopathy.格雷夫斯眼病。
N Engl J Med. 2010 Feb 25;362(8):726-38. doi: 10.1056/NEJMra0905750.
7
Orbital radiotherapy for thyroid-related orbitopathy.甲状腺相关性眼病的眼眶放射治疗。
Curr Opin Ophthalmol. 2004 Dec;15(6):479-82. doi: 10.1097/01.icu.0000144388.89867.03.
8
Somatostatin analogs: a new tool for the management of Graves' ophthalmopathy.生长抑素类似物：一种用于治疗Graves眼病的新工具。
J Endocrinol Invest. 2004 Mar;27(3):281-7. doi: 10.1007/BF03345278.
9
A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.一项针对轻度格雷夫斯眼病患者的眼眶放射治疗与假照射的随机对照试验。
J Clin Endocrinol Metab. 2004 Jan;89(1):15-20. doi: 10.1210/jc.2003-030809.
10
Long-term safety of orbital radiotherapy for Graves' ophthalmopathy.格雷夫斯眼病眼眶放射治疗的长期安全性
J Clin Endocrinol Metab. 2003 Aug;88(8):3561-6. doi: 10.1210/jc.2003-030260.